Skip to content

Clinical trials

Phase 3 Liver Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 3 Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20131
20191
20201
20211
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Mirum Pharmaceuticals, Inc.2
Abbott1
Centre Hospitalier Universitaire, Amiens1
Gilead Sciences1
GlaxoSmithKline1
Inventiva Pharma1
Janssen R&D Ireland1
Vir Biotechnology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases11
Digestive System Diseases7
Non-alcoholic Fatty Liver Disease4
Fibrosis3
Hepatitis3
Hepatitis C3
Bile Duct Diseases2
Biliary Tract Diseases2
Cholestasis2
Fatty Liver2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.